MaryRuth's Secures $420 Million Debt Deal, Boosting Founder’s Billion-Dollar Valuation

MaryRuth’s, an organic vitamin and supplement company founded by MaryRuth Ghiyam in 2014, completed a $420 million debt financing package with Capital One in October 2025, structuring the loan to mature in 2030 while keeping Ghiyam’s ownership at about 97%. The financing came after the brand, which generates roughly $600 million in annual revenue and $125 million in EBITDA, turned down multiple nine-figure acquisition offers from firms such as Blackstone, Summit Partners and Butterfly Equity.

Earlier private-equity deals helped double sales to over $270 million by 2023, but a later exit attempt was halted when Ghiyam’s divorce triggered a post-nuptial clause granting her former husband half of any future sale proceeds. Forbes now values Ghiyam’s personal stake at about $750 million, down from a potential $1.5 billion billionaire status. Capital One’s managing director Paul Baisley praised Ghiyam’s data-driven approach and sees long-term growth potential, though the founder acknowledges the pressure of possible future ownership changes. The deal reflects the broader trend of consumer-packaged-goods firms leveraging debt to fund expansion while maintaining founder control.